acrolein has been researched along with 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, XQ; Gui, SY; Gui, ZP; Shan, QQ; Wan, J; Wang, SM; Yang, Y; Yang, ZZ | 1 |
Chu, X; Gui, S; Jiang, J; Liu, L; Tian, C; Wang, X; Xia, M | 1 |
2 other study(ies) available for acrolein and 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol
Article | Year |
---|---|
Phytantriol-based lyotropic liquid crystal as a transdermal delivery system.
Topics: Acrolein; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Drug Delivery Systems; Fatty Alcohols; Interleukin-1beta; Knee Joint; Liquid Crystals; Male; Rats; Rats, Wistar; Skin; Skin Absorption; Tumor Necrosis Factor-alpha | 2018 |
Dual drug-loaded cubic liquid crystal gels for transdermal delivery: inner structure and percutaneous mechanism evaluations.
Topics: Acrolein; Administration, Cutaneous; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Carriers; Drug Combinations; Drug Compounding; Drug Evaluation, Preclinical; Drug Liberation; Fatty Alcohols; Gels; Hydrophobic and Hydrophilic Interactions; Liquid Crystals; Male; Morphinans; Rats; Skin; Water | 2019 |